ASCO: Bristol Myers unveils I-O triplet data in melanoma as

Over the years, melanoma has become a popular testing ground for researchers to explore new immuno-oncology approaches.

Related Keywords

United States , American , Graf Finckenstein , Friedrich Graf Finckenstein , Bristol Opdivo , Merck Co , American Society Of Clinical Oncology , Bristol Myers Squibb , Bristol Myer , American Society , Clinical Oncology , Leerink Partners , Fierce Pharma ,